Great West Life Assurance CO Nurix Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 4,876 shares of NRIX stock, worth $120,632. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,876Holding current value
$120,632% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding NRIX
# of Institutions
183Shares Held
66.4MCall Options Held
40.9KPut Options Held
106K-
Black Rock Inc. New York, NY6.82MShares$169 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.42MShares$109 Million6.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.99MShares$98.7 Million2.73% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$96 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$89.7 Million0.0% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $1.17B
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...